Hamilton Thorne Ltd.
HTL
Classificação em ações
#16953
Hamilton Thorne Ltd. is a leading enterprise focused on the development,... Hamilton Thorne Ltd. is a leading enterprise focused on the development, manufacturing, and global distribution of specialized instrumentation, laboratory equipment, consumables, software, and a range of services. The company's offerings are primarily directed towards the fields of assisted reproductive technologies (ART), scientific research, and cell biology. Their product line includes sophisticated laser and imaging systems designed for biological studies, custom-built workstations, incubators, and essential equipment for IVF laboratories. They also produce critical medical devices for reproductive medicine, such as ovum pickup needles and catheters, and provide comprehensive in-vitro diagnostic (IVD) systems, from initial research and design to sales, installation, and ongoing servicing. Environmental control solutions like the Cell-Tek Microscope Chamber, which meticulously manages temperature, airflow, and humidity, are also part of their extensive catalog, alongside laminar flow workstations. Furthermore, Hamilton Thorne pioneers software innovations, including AI-powered CASA (Computer-Assisted Sperm Analysis) for image analysis. The company's service array covers thorough laboratory testing, notably endotoxin analysis and specialized sperm assays (like the Sperm Motility Index and Sperm Penetration), as well as the provision of fresh and cryopreserved mouse embryos, coupled with technician training and proficiency testing programs. Marketed under respected brand names such as Hamilton Thorne, Gynemed, Planer, Tek-Event, IVFtech, MICROPTIC, Gynétics, and Embryotech, their products and services reach a diverse global customer base—including fertility clinics, hospitals, pharmaceutical and biotechnology companies, academic institutions, and various commercial research entities—via a direct sales presence in countries like the United States, Germany, France, Australia, Denmark, Belgium, Spain, and the United Kingdom, complemented by an extensive distributor network covering around 100 nations. Hamilton Thorne Ltd. maintains its headquarters in Beverly, Massachusetts.
Preço da ação
$1.64
Última sincronização: 2024-12-02
Valor de mercado
$253.46M
Variação (1 dia)
2.87%
Variação (1 ano)
3.40%
País
US
Negociar Hamilton Thorne Ltd. (HTL)
Categoria
Healthcare
Rácio P/E de Hamilton Thorne Ltd. (HTL)
Rácio P/E em October 2026 TTM: -387.83
De acordo com os últimos relatórios financeiros e o preço das ações da Hamilton Thorne Ltd., o rácio P/E atual (TTM) é -387.83. No final de 2022, a empresa tinha um P/E de 91.33.
Histórico do rácio P/E da Hamilton Thorne Ltd. de 2008 a 2026
Rácio P/E no final de cada ano
| Ano | Índice P/E | Alterar |
|---|---|---|
| 2026 (TTM) | -387.83 | 59.24% |
| 2023 | -243.55 | -366.69% |
| 2022 | 91.33 | -4.30% |
| 2021 | 95.43 | -39.39% |
| 2020 | 157.45 | 26.56% |
| 2019 | 124.41 | 371.95% |
| 2018 | 26.36 | 161.23% |
| 2017 | 10.09 | -72.34% |
| 2016 | 36.48 | 279.55% |
| 2015 | 9.61 | -56.10% |
| 2014 | 21.90 | 14.40% |
| 2013 | 19.14 | -996.31% |
| 2012 | -2.14 | 72.31% |
| 2011 | -1.24 | 28.28% |
| 2010 | -0.97 | 40.85% |
| 2009 | -0.69 | 565.28% |
| 2008 | -0.10 | 0.00% |
Rácio P/E para empresas semelhantes ou concorrentes
| Empresa | Rácio P/E | Diferença do rácio P/E | País |
|---|---|---|---|
| 47.48 | -112.24% |
US
|
|
| 27.43 | -107.07% |
FR
|
|
| - | - |
JP
|
|
| 56.89 | -114.67% |
US
|
|
| - | - |
CH
|
Como interpretar um P/E Ratio?
O rácio Preço/Lucro (P/E) mede a relação entre o preço da ação de uma empresa e o lucro por ação.
Um P/E baixo mas positivo representa uma empresa com altos lucros face à sua valorização atual e pode estar subvalorizada. Um P/E negativo elevado (perto de 0) representa perdas significativas.
Empresas com P/E acima de 30 ou negativo são geralmente vistas como "ações de crescimento", significando que os investidores esperam crescimento ou rentabilidade futura.
Empresas com P/E positivo inferior a 10 são geralmente consideradas "ações de valor", ou seja, já são muito lucrativas mas com pouco potencial de crescimento.